Veterinary Dermatology Drugs Market Will Reach US$ 9.8 Bn by 2030


The global veterinary dermatology drugs market size was valued at US$ 3.5 bn in 2020 and is anticipated to hit around US$ 9.8 billion by 2030.

Veterinary Dermatology Drugs Market (By Product Type: Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs, Others; By Mode of Administration: Topical, Oral, and Injectable; By Animal Type; By Indication) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@

Veterinary Dermatology Drugs Market Size 2021 to 2030


Veterinary dermatology, also referred as pet skin care, involves diagnosis, treatment, and prevention of skin problems in animals. Dermatological disorders or skin disorders are the most common medical conditions seen in animals. The most common sign of a dermatological problem in animals are licking, biting, repeatedly shaking the head, and excessive scratching or chewing of fur and skin. Additional symptoms of skin problems include lumps, hair loss, dandruff, a foul odor from ears or skin, and change in the texture or color of pet’s fur or skin. Itching is commonly seen in companion animals; atopic dermatitis is the common cause of itching.

According to a research conducted by the Ferdowsi University of Mashhad Veterinary Teaching Hospital, 20% to 40% of small animals suffered from skin problems in Iran in 2013–2014. Globally, this number may be even higher. Variations in clinical presentations such as the extent of lesions, genetic factors, secondary infections, stage of the disease, and weather conditions could complicate the exact diagnosis of the disease. Atopy is genetically determined predisposition to become allergic to airborne pollens such as grass, weeds, trees, mold, and house dust. In domestic pets such as cats and dogs, atopic dermatitis is the most common cause of biting, chewing, rubbing, or ear infections as well as other chronic infections.

Increase in Medical and Diagnostic Capabilities for Companion Animals to Drive Global Market

The global veterinary dermatology drugs market continues to grow at a rapid pace. The market is driven in developed countries by improved diagnostic and medical capabilities for companion animals. There is a rise in the demand for local anesthetics, anti-inflammatory agents, emollients to treat acne, cleansers, and anti-infectives. Moreover, increase in the demand for veterinary and related products such as dairy and agriculture products and rise in awareness about veterinary dermatology drugs are anticipated to drive the global veterinary dermatology drugs market.

Increase in Ownership of Companion Animals to Fuel Market Growth

Rise in companion animal ownership is a significant trend in the animal healthcare segment. In 2013, around 62% of the U.S. households owned a companion animal (excluding horses) i.e., around 72.9 million homes. Brazil, China, India, Mexico, and Russia are among the top countries with a high growth rate in terms of companion animal ownership.

Report Scope

In terms of product type, the global veterinary dermatology drugs market has been classified into antifungal drugs, antibacterial drugs, antiparasitic drugs, and others. The antibacterial drugs segment dominated the global veterinary dermatology drugs market in 2020, owing to high prevalence of bacterial infection among animals and rise in usage of antibacterial drugs.

Based on mode of administration, the global veterinary dermatology drugs market has been categorized into oral, topical, and injectable. The topical segment captured the largest market share in 2020, as it is among the oldest and most efficient mode of administration of drugs to control inflammatory and immune-mediated skin disorders.

In terms of animal type, the global veterinary dermatology drugs market has been bifurcated into large animals and small animals. The large animals segment has been split into equine, bovine, and others. The small animals segment has been segregated into cats, dogs, and others.

Based on indication, the global veterinary dermatology drugs market has been divided into infectious diseases, skin cancer, autoimmune skin diseases, parasitic infections, and others. The infectious diseases segment accounted for significant share of the market in 2020, as infectious diseases are the most common type of veterinary dermatology conditions in companion as well as livestock animals.

In terms of region, North America is projected to be a highly attractive market for veterinary dermatology drugs from 2021 to 2031. High revenue from the region can be attributed to increase in government and private funding and large volume of tests performed. North America is also home to several key players such as Idexx, VCA, and Thermo Fisher, which further propels the market.

The veterinary dermatology drugs market in Asia Pacific is expected to be driven by high adoption of veterinary dermatology drugs, vaccines, and medicated feed additives for the well-being of the rapidly increasing livestock animal population in the region

Key players operating in the global veterinary dermatology drugs market are

    • Merial, Zoetis, Inc.
    • Ceva Sante Animale
    • Vetmedica
    • IDEXX Laboratories
    • Vetoquinol S.A.
    • Virbac S.A.
    • Bayer Animal Health
    • Boehringer Ingelheim
    • Elanco
    • Novartis Animal Health
    • Toray Industries
    • AB Science

Buy This Premium Research Report, click here@ or call: +1 9197 992 333


Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published. Required fields are marked *